Skip to content

DR.R.BLONTROCK

Active
Private limited companyfounded 2005active for 21 yearsKoolaerdstraat 120, 8470 Gistel, BelgiumKBO/BCE: BE 0875.935.041
Summary

DR.R.BLONTROCK has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.2m and a net result of €134,544. Equity has been growing by about 13% per year since 2018. Its solvency ranks better than 88% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 08-09-2005 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.234.053.619 8470 Gistel, since 02-09-2005
Financial year end
31 December
Peppol
Reachable since 25-11-2025

Board and ownership

Board

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€204,786
▼ 10.6%
Turnover
≈ €380,000
estimated
Profit
€134,544
▼ 11.1%
Equity
€1.2m
▲ 12.6%
Total assets
€1.3m
▲ 11.6%
  • 2025 accounts filed 27 days after the deadline
Score breakdownlowers riskLiquidity: current ratio 14.13, cash €1.3mSector: Human health activities (NACE 86)Equity €1.2m (92.5% of total assets)Size: total assets €1.3mShow the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 65% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 92.5% of total assets
Liquidity 100=
short-term debt 7.1% · cash 98.3%
Profitability 82-3
return on assets 10.4%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025highest value 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €110,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 14.13 (12.78 in 2024), above the usual 1.5. Short-term debt is 7.1% and cash 98.3% of total assets. 7.5% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 95% on liquidity, 29% on profitability and 56% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
lowers risk · Liquidity: current ratio 14.13, cash €1.3m
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Equity €1.2m (92.5% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €1.3m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · 2025 accounts filed 27 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
27 days late
2024
7 days late
2023
12 days late
2022
21 days early
2021
11 days late
2020
1 day early
2019
31 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 9 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 11 August (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: More equity than 95% of companies in human healthsector median €124,659 · 20,702 companies €1.2m View
  • Positive: 8 profitable years in a rowprofit 2025: €134,544 8 years View

Recent changes

  1. · Gazette deed Change of role: Robert BLONTROCK, from statutory manager to directorAppointment: BLONTROCK Joost Gerard Adrien (opvolgend niet statutair bestuurder)
  2. · Gazette deed Incorporation
All 14 events

Comparable companies

These companies have the same main activity as DR.R.BLONTROCK: general medical practice (NACE 86210). They are comparable in size and age: total assets between €1.2m and €1.4m, founded between 2002 and 2007.

CompanyTotal assetsGross margin
DR.R.BLONTROCK Gistel€1.3m€0.2m
DR. LEIRE JAN Zonnebeke€1.2m€0.2m
DR. IGNACE BERGEZ Wingene€1.2m€0.2m
DR. LUC BOSTOEN Moorslede€1.4m€0.2m
LUC VANNESTE Wevelgem€1.3m€0.2m
DOKTERS MOUBAX EN VUYLSTEKE As€1.3m€0.2m
DOKTER BONAMI Aalter€1.3m€0.2m
Full comparison

Key facts about DR.R.BLONTROCK

What is the company number of DR.R.BLONTROCK?
The company number of DR.R.BLONTROCK is 0875.935.041. The VAT number is the same number with BE in front: BE 0875.935.041.
Where is DR.R.BLONTROCK based?
The registered office is at Koolaerdstraat 120, 8470 Gistel.Company details
What does DR.R.BLONTROCK do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR.R.BLONTROCK?
The legal form of DR.R.BLONTROCK is Private limited company (BV).
When was DR.R.BLONTROCK founded?
DR.R.BLONTROCK was founded on 08-09-2005.
Is DR.R.BLONTROCK still active?
Yes, DR.R.BLONTROCK is an active enterprise in the KBO register.
What is the turnover of DR.R.BLONTROCK?
The turnover in financial year 2025 is ≈ €380,000. This figure is estimated from the gross margin of €204,786 and 30 comparable companies (NACE 86210). It probably lies between €300,000 and €460,000.Financials
Is DR.R.BLONTROCK profitable?
In financial year 2025, DR.R.BLONTROCK made a profit of €134,544.
Where can I find the annual accounts of DR.R.BLONTROCK?
DR.R.BLONTROCK filed 21 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR.R.BLONTROCK due?
DR.R.BLONTROCK must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.